Exciva

Heidelberg, Germany · Founded 2015 · Privately Held (backing)

Developer of antitussive medication designed to address both the neurological and psychological aspects of behavioral and psychological symptoms. Exciva is based in Heidelberg, Germany and was founded in 2015. Its last reported valuation was $16.4 million in Oct 2021. It has raised $70.1 million.

Last reported valuation
$16.4M
Oct 2026
Priced at
—
Total raised
$70.1M
Last round
—

Who backs Exciva?

9 investors
InvestorType
EQT Life SciencesVenture capital
Modi VenturesVenture capital
Andera PartnersPE / buyout
LBBW Venture CapitalOther
LifeArcOther
CARMA FUND Management—
Cure8 Ventures—
Fountain Healthcare Partners—
Gimv—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Exciva investors

9 investors are on record for Exciva, including EQT Life Sciences, Modi Ventures, Andera Partners and LBBW Venture Capital.

Free account
More of Exciva with a free account
  • ·Watch Exciva: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Exciva. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View